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In Vivo X-Ray Imaging Reveals Improved
Airway Surface Hydration after a Therapy
Designed for Cystic Fibrosis
To the Editor:
Sufficient airway surface liquid (ASL) depth is critical to ensure that
the mucociliary transport system can effectively clear inhaled
pathogens from the lungs. In those with cystic fibrosis (CF), the CF
transmembrane conductance regulator gene defect decreases airway
surface hydration (1, 2), compromising lung defense mechanisms,
resulting in progressive lung infection and early death (3). An
effective CF respiratory therapy should increase the ASL depth,
restoring clearance mechanisms, but it is difficult to measure this
depth in vivo. Current clinical health measures used for CF drug
development studies include lung function testing and structural
lung imaging (i.e., computed tomography), both indirect and
delayed measures of airway hydration. Although the ASL depth
has been measured by confocal microscopy in epithelial cultures
(1, 4) and histologically in fragments of trachea (5), these
technologies are not feasible in vivo.
We have realized a technique called single-grid–based
phase–contrast X-ray imaging (SGB-PCXI) (Figure 1A) (6–9),
which is capable of non-invasive ASL imaging, and we previously
demonstrated its ability to measure the ASL rehydrating effects
of aerosolized hypertonic saline (HS) in the excised trachea of
a mouse (10). In this letter, we report the first in vivo measures
of ASL using this technique.
PCXI methods capture information on how the sample refracts
the X-ray wavefield to provide exquisite soft tissue images. This
differs from conventional X-ray imaging, where absorption of the
X-ray wavefield provides very little soft tissue contrast (11). ASL
measurements were not feasible with previous PCXI methods,
which lacked either the speed to capture these high-magnification
images without motion blur, or the sensitivity to differentiate ASL
from surrounding tissue. Our SGB-PCXI method provides the
necessary speed and sensitivity by illuminating the airways with
a grid pattern. At the image detector, the grid will appear distorted
according to the refractive properties of the airway tissue, in the
same way the tile pattern on the bottom of a swimming pool will
appear distorted according to the refractive properties of the water
(10). By analyzing these distortions, we can quickly and sensitively
produce an image of the ASL (6–8).
Using SGB-PCXI, we measured the effects of a two-agent
rehydrating treatment—an aerosol containing a long-acting epithelial
sodium channel blocker (P308; Parion Sciences, Durham, NC), at
a concentration of 1 mM in 7% HS—on ASL depth in live,
anesthetized mice. C57Bl/6 mice (n = 14) were prepared for ventilation
and imaging, as previously detailed (12), and placed in a supine
position so that the ventral surface could be imaged to avoid multiple
overlaid tracheal edges and ensure that any bulk fluid formed during
aerosol delivery did not pool in the field of view. Treatments were
delivered using an Aeroneb Pro nebulizer (Aerogen, Galway, Ireland),
designed to produce 3.5-mm volume median diameter aerosol,
integrated in the ventilator system, for a period of 90 seconds, 50% duty
cycle. For each mouse, images of the ventral tracheal surface were
captured at 3-minute intervals, before and for 15 minutes after delivery
of the control (isotonic saline) treatment; after a break of 5 minutes, the
15-minute imaging sequence was repeated in the same mouse then
being delivered the HS-P308 treatment (Figure 1D).
Before any image analysis was performed, six mice were rejected
from the study (leaving n = 8). One mouse shifted position such that
the airway moved out of the field of view; for two mice, the custom-
built nebulizer control system malfunctioned; and in three mice, the
intubation was placed too deeply into the airway for tracheal aerosol
delivery (with the position observed immediately when X-ray
imaging began). This failure rate illustrates the initial technical
difficulty involved with these complex experiments, but sufficient
sample size remained. We anticipate that these problems will decrease
with experience, as in our previous imaging development work.
Measurements were made (observer blinded to treatment) by
manually tracing the tissue–cartilage, tissue–ASL, and ASL–airway
interfaces. Manual traces showed an acceptably high intraclass
correlation of 0.992 between five different scorers in our previous
study (10). The distance between marked interface lines was
measured computationally, taking the average distance over the
length of airway traced in that image. Measures taken at all time
points were then analyzed by repeated-measures ANOVA (Prism
5; GraphPad, San Diego, CA).
Although the presence of overlying tissue and skin in vivo
reduces the visibility of the subtle ASL–tissue interface compared
with our previous ex vivo studies (10), ASL depth measurements
were still possible, as seen by the left bracket in Figure 1B. The HS-
P308 sequences showed lumen movement and increased ASL depth
after treatment delivery (Figure 1C). The control (isotonic saline)
sequences showed very little movement throughout, and this low,
stationary ASL made it difficult to reliably identify the ASL–tissue
interface, particularly given the obscuring influence of overlying skin/
tissue. Therefore, to quantify biological changes in response to isotonic
saline versus HS-P308, we measured the distance between the
outer edge of a reference cartilage ring and the ASL–airway lumen
interface, as indicated by the bracket in the right of Figure 1B.
A statistically significant increase in the position of the ASL
surface (relative to the cartilage) was observed in the airways treated
with HS-P308 compared with the earlier isotonic saline treatment
for all time points after and including 6 minutes after aerosol
delivery, as seen in Figure 1D. In the direct measures of ASL
depth (Figure 1C) there was a significant increase in depth
compared with baseline at 9 and 12 minutes after delivery of
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HS-P308. Although some mice showed a large increase within
3 minutes of treatment delivery, others had a more delayed effect,
resulting in a large spread of values at 3 minutes. A similarly
large spread of values was seen at 15 minutes, when the treatment
effect may have waned for some of the mice, increasing the
variability of the dataset at that final time point.
The relative increase in the ASL depth was of similar magnitude
to that seen in our ex vivo study (10), with the average depth
increasing by a maximum of 10–15 mm. This effect is consistent
in magnitude and duration with tissue culture studies (13). It is
interesting to note that the increase in the cartilage-to-airway
measure (Figure 1D) was greater than the increase in ASL depth
measure (Figure 1C, subtracting baseline), peaking at around
30 mm compared with 10 mm. This finding suggests that there
may be additional liquid drawn from surrounding tissue into the
submucosal compartment, causing that region to swell and raise the
surface of the liquid further from the cartilage. In contrast, our ex vivo
studies observed a decrease in airway tissue volume from 3 minutes
Figure 1. (A) Experimental setup using 25-keV X-rays at beamline BL20XU at the SPring-8 synchrotron in Japan, using the setup described in Reference
10, with a gold absorption grid of 25.4-mm period (Gilder grids, G1000HS-G3), and distances of 0.1 m grid-to-sample and 1 m sample-to-detector.
The lens-coupled charge-coupled device detector captures a 721 3 497-mm field of view with 0.18-mm pixels using a 100-ms exposure. Airway images
are reconstructed using a correlation-based analysis detailed in References 6–8. (B) Single-grid–based phase–contrast X-ray imaging (SGB-PCXI)
differential contrast image of the in vivo trachea surface. Scale bar = 100 mm. (C) Airway surface liquid (ASL) depth measurements, where each data
point represents a measurement, and the darker bars indicate the mean (6SD) of measurements at that time point. Hypertonic saline (HS)–P308
was delivered after the t = 0 time point, analyzed by one-way repeated-measures (RM)-ANOVA to detect differences compared to baseline (t = 0).
Statistical significance was set at a P value of 0.05 and a power of 0.8 for all analyses. (D) Changes in the cartilage-to-surface distance over time, analyzed
by two-way RM-ANOVA with Bonferroni multiple comparisons to detect significant differences between treatments at matching time points. In the
5-minute break between sequences, researchers entered the imaging hutch to change the treatment solution.
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after treatment, when there was no surrounding tissue present (10).
This difference illustrates the importance of conducting studies in vivo
when assessing a physiological response to treatment. We also
noted that the treatment effect lasted longer in vivo with HS-P308
treatment compared with ex vivo with HS treatment. Because both the
treatment agent and the nature of the measurements (in/ex vivo)
were different between this and previous studies, we cannot determine
which factor produced this extended effect.
We believe that these are the first reported noninvasive in vivo
measurements of changes in ASL volume (depth) in response to
an airway-rehydrating treatment. Our transition from ex vivo to
in vivo imaging is significant, enabling biologically relevant results,
longitudinal studies, and treatment delivery technique studies.
The research and clinical utilities of a rapid, noninvasive ASL
depth measurement technique are significant. Although clinical
implementation presents some challenges, continuing developments
in image detectors and compact X-ray sources suitable for PCXI mean
that this is still a possibility, although some compromises in image
quality may be necessary to reduce radiation dose. In addition,
these kinds of technical developments will certainly improve the
accessibility, speed, and spatial resolution of our technique for
research (note the use of light at X-ray wavelengths means that our
images are several orders of magnitude from the fundamental spatial
resolution limits). Direct observations of in vivo changes in the ASL
depth immediately after application of known or potential therapies
can lead to a better understanding of how CF transmembrane
conductance regulator gene, protein, and channel activity alterations
influence fundamental airway surface ion–water balance processes.
Furthermore, rapid and accurate in vivo physiological outcome
assessments of drugs emerging from the CF pharmaceutical
development pipeline can be made at the site of action, and reveal
biophysical mechanisms that precede more global measurements of
airway function (e.g., FEV1). Studies can also examine a range of
disease models, and the noninvasive nature of this new measure
means that repeat measures can be captured on the same animals
across a range of time scales (14). n
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